Dr Ravi Gaur, COO, Oncquest Laboratories Ltd, New Delhi

  • 26-08-2016 05:45:53
  • Artificial Intelligence

Need to have devices more focused on prevention & monitoring
Affordable, accessible devices that can be used at the peripheral level are required

Key Takeaways:
We are into high-end technology testing where technologies are very expensive; therefore, inhouse systems need to be developed to validate these technologies to bring down cost
Need to have a big R&D lab to test medical devices to cut down investment & ultimately cost